CENTURION ILAC SANAYI VE TICARET AN — Vaccine Importer Profile
Pharmaceutical Importer · #13 buyer for Vaccine · $2.6M import value · 57 shipments · TURKEY · DGFT Verified
CENTURION ILAC SANAYI VE TICARET AN is the #13 importer of Vaccine from India with $2.6M in import value and 57 verified shipments. CENTURION ILAC SANAYI VE TICARET AN holds a 0.2% market share in Vaccine imports based in TURKEY. The company sources from 1 verified supplier across 24 formulations shipped to 1 country. Overall, CENTURION ILAC SANAYI VE TICARET AN imports 2 pharmaceutical products worth $3.8M across 2 therapeutic categories.
CENTURION ILAC SANAYI VE TICARET AN — Vaccine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vaccine to CENTURION ILAC SANAYI VE TICARET AN?
Verified from 57 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INDIAN IMMUNOLOGICALS LIMITED | $2.6M | 57 | 100.0% |
CENTURION ILAC SANAYI VE TICARET AN sources Vaccine from 1 verified Indian supplier based on 57 customs records. The primary supplier is INDIAN IMMUNOLOGICALS LIMITED accounting for 100.0% of imports.
How Does CENTURION ILAC SANAYI VE TICARET AN Compare to Nearest Vaccine Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | XXICEXXSUPXXY DXXISIXX | AFGHANISTAN | $2.4M | 48 | $50.0K |
| 11 | EXPANDED PROGRAMME ON IMMUNIZATION | PAKISTAN | $2.3M | 45 | $50.0K |
| 13 | CENTURION ILAC SANAYI VE TICARET AN ★ | TURKEY | $2.1M | 42 | $50.0K |
| 3 | NATIONAL VACCINES AND IMMUNIZATION | KENYA | $1.9M | 37 | $50.0K |
| 16 | 2 WORLD TRADERS INC | PHILIPPINES | $1.6M | 33 | $50.0K |
CENTURION ILAC SANAYI VE TICARET AN ranks #13 among 2,202 Vaccine importers from India. Average shipment value of $50.0K compared to the market average of $17.3K. The closest competitors by value are XXICEXXSUPXXY DXXISIXX and EXPANDED PROGRAMME ON IMMUNIZATION.
Where Does CENTURION ILAC SANAYI VE TICARET AN Import Vaccine To?
Destination countries from 57 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $2.6M | 57 | 100.0% |
CENTURION ILAC SANAYI VE TICARET AN imports Vaccine to 1 country. The primary destination is TURKEY receiving 100.0% of shipments worth $2.6M.
What Vaccine Formulations Does CENTURION ILAC SANAYI VE TICARET AN Import?
| Formulation | Value | Shipments |
|---|---|---|
| ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT) | $1.3M | 26 |
| ABHAYRAB 0.5MLHUMAN RABIES VACCINE WITH | $200.0K | 4 |
| ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINE | $150.0K | 3 |
| ABHAYRAB 0.5 ML B.P(HUMAN RABIES VACCINE | $100.0K | 2 |
| ABHAYRAB 0 5ML B P HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT | $50.0K | 1 |
| ABHAYRAB 0 5 ML B P HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT BATCH NO 22URAB081 MFG DT JAN 2023 EXP D | $50.0K | 1 |
| ABHAYRAB 0 5 ML B P HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT BATCH NO 22URAB079 MFG DT JAN 2023 EXP D | $50.0K | 1 |
| ABHAYRAB 0 5 ML B P HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT BATCH NO 22URAB081 MFG DT JAN 2023 EXP DT | $50.0K | 1 |
| ABHAYRAB 0.5ML B.P (HUMAN RABIES VACCINE | $50.0K | 1 |
| ABHAYRAB 0.5ML B.P.(HUMAN RABIES VACCINE | $50.0K | 1 |
CENTURION ILAC SANAYI VE TICARET AN imports 24 distinct Vaccine formulations from India. The top formulation is ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRIN with 26 shipments worth $1.3M.
Who Are the Top Buyers of Vaccine from India and How Much Does CENTURION ILAC SANAYI VE TICARET AN Import?
India exported $38.1M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. CENTURION ILAC SANAYI VE TICARET AN imports $2.6M of this total, accounting for 0.2% of India's Vaccine exports with 57 shipments from TURKEY. This is verified from 57 customs shipment records covering 24 distinct formulations.
What Is the Average Order Value for CENTURION ILAC SANAYI VE TICARET AN's Vaccine Imports?
CENTURION ILAC SANAYI VE TICARET AN's average Vaccine order value is $44.7K per consignment, based on 57 shipments totaling $2.6M. CENTURION ILAC SANAYI VE TICARET AN is based in TURKEY and ranks #13 among all Vaccine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vaccine to CENTURION ILAC SANAYI VE TICARET AN?
CENTURION ILAC SANAYI VE TICARET AN sources Vaccine from 1 verified Indian supplier: INDIAN IMMUNOLOGICALS LIMITED ($2.6M, 100.0%). This is based on 57 customs records.
How Does CENTURION ILAC SANAYI VE TICARET AN Compare to Other Vaccine Importers?
CENTURION ILAC SANAYI VE TICARET AN ranks #13 among 2,202 Vaccine importers from India with a 0.2% market share. The top 3 importers are NATIONAL PRIMARY HEALTH CARE ($6.3M), UNICEF SUPPLY DIVISION ($5.0M), MINISTRY OF HEALTH ($4.5M). CENTURION ILAC SANAYI VE TICARET AN processed 57 shipments from TURKEY.
About CENTURION ILAC SANAYI VE TICARET AN
CENTURION ILAC SANAYI VE TICARET AN imports 2 products worth $3.8M. Beyond Vaccine, top products include Syringe. View the complete CENTURION ILAC SANAYI VE TICARET AN profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CENTURION ILAC SANAYI VE TICARET AN matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CENTURION ILAC SANAYI VE TICARET AN's capped import value divided by total capped export value for Vaccine across all Indian exporters.
- 5.Verified Records: This page is backed by 57 individual customs records matching CENTURION ILAC SANAYI VE TICARET AN importing Vaccine, covering 24 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Import Data for CENTURION ILAC SANAYI VE TICARET AN
Access order-level details, pricing data, supplier connections, and competitive analysis for CENTURION ILAC SANAYI VE TICARET AN's Vaccine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CENTURION ILAC SANAYI VE TICARET AN
Full Company Profile →
2 products · $3.8M total trade · 2 categories
CENTURION ILAC SANAYI VE TICARET AN × Vaccine
Verified from customs records
Company Overview
Top Products by CENTURION ILAC SANAYI VE TICARET AN
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CENTURION ILAC SANAYI VE TICARET AN.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current order-level data, contact TransData Nexus.